386900007: Palivizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Palivizumab (substance)
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Palivizumab (substance)

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Palivizumab (substance)
\Drug or medicament (substance)\Immunosuppressant (substance)\Palivizumab (substance)
\Drug or medicament (substance)\Monoclonal antibody\Palivizumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Palivizumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Palivizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461078016 Palivizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481014019 Palivizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

830751000172117 palivizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

830761000172115 palivizumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Palivizumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Palivizumab (substance)	Is a	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Palivizumab (substance)	Is a	Substance with antiviral mechanism of action (substance)	true	Inferred relationship	Some
Palivizumab (substance)	Has disposition (attribute)	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Palivizumab (substance)	Has disposition (attribute)	Immunomodulator (disposition)	true	Inferred relationship	Some
Palivizumab (substance)	Has disposition (attribute)	Antiviral (disposition)	true	Inferred relationship	Some
Palivizumab (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing palivizumab (medicinal product)	Has active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab 50mg powder and solvent for injection solution vial	Has active ingredient	False	Palivizumab (substance)	Inferred relationship	Some
Palivizumab 100mg injection	Has active ingredient	False	Palivizumab (substance)	Inferred relationship	Some
Palivizumab 100mg powder for injection 1mL vial	Has active ingredient	False	Palivizumab (substance)	Inferred relationship	Some
Palivizumab 100mg powder and solvent for injection solution vial	Has active ingredient	False	Palivizumab (substance)	Inferred relationship	Some
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	Has precise active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab 50 mg powder for solution for injection vial	Has basis of strength substance (attribute)	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab-containing product in parenteral dose form	Has active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab only product	Has active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Palivizumab only product in parenteral dose form	Has active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Palivizumab (substance)	Inferred relationship	Some	1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Palivizumab (substance)	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug